Mold Exposure and Health Effects

Established Health Effects of Mold

The American Academy of Pediatrics identifies well-documented mold-related health effects, including respiratory manifestations such as allergic rhinitis, asthma exacerbations, cough, and wheezing, in individuals exposed to mold 1, 2
Mold exposure can cause mucous membrane irritation, affecting eyes, nose, and throat in both sensitized and non-sensitized individuals 2
Allergic conditions such as allergic bronchopulmonary aspergillosis, allergic fungal sinusitis, and hypersensitivity pneumonitis can occur in rare cases due to mold exposure 1, 2

If a patient reports headaches in a mold-contaminated environment, consider primary respiratory symptoms such as nasal congestion, rhinorrhea, cough, or asthma symptoms that are actually caused by mold 3
Sinus complications such as secondary bacterial sinusitis from allergic obstruction can cause facial pain and headache in patients exposed to mold 3
Alternative diagnoses such as severe headache warrants investigation for other conditions including CSF leak or tumors, not attribution to mold 3

The American Academy of Pediatrics recommends evaluating for established mold-related conditions first, such as allergic rhinitis, asthma, or sinusitis, through focused history, physical examination of nasal mucosa, and allergy testing via skin prick testing or specific IgE to mold allergens 3
Address the environment regardless of headache symptoms, as moisture control and mold remediation should occur because mold causes documented respiratory harm 4, 5
Investigate alternative headache etiologies and do not attribute headaches to mold without ruling out primary headache disorders, sinus disease, or other neurological conditions 3

The American Academy of Pediatrics provides clear guidance on environmental remediation, including cleaning water damage within 24 hours to prevent mold amplification 4, 5, 6
Maintaining indoor humidity below 50% using dehumidifiers is recommended to prevent mold growth 5, 6
For areas less than 10 square feet, individuals can perform cleanup with soap and water or bleach solution, while larger areas or HVAC involvement require professional remediators 6, 7

The American Academy of Pediatrics explicitly states that there is no validated method to test humans for toxigenic mold exposure, and mycotoxin testing in blood or urine should not be ordered 7, 8
Delaying investigation of serious headache symptoms by attributing them to mold exposure may miss life-threatening conditions, and alternative diagnoses should be considered 3

The American Academy of Pediatrics identifies respiratory manifestations as the primary health effects of indoor mold exposure, including allergic rhinitis, asthma exacerbations, cough, wheezing, and nasal congestion. 9
Mucous‑membrane irritation of the eyes, nose, and throat occurs in both sensitized and non‑sensitized individuals exposed to mold. 9
Rare allergic conditions such as allergic bronchopulmonary aspergillosis, allergic fungal sinusitis, and hypersensitivity pneumonitis may develop after mold exposure. 9

The Institute of Medicine concluded that the existing literature does not allow a definitive association between mold exposure and neuropsychiatric symptoms because of insufficient and low‑quality evidence. 9
The American Academy of Pediatrics states that no validated clinical test exists to detect toxigenic mold exposure in humans. 9

No peer‑reviewed medical literature establishes indoor mold exposure as a cause of seizures. 9
Seizures are absent from the list of health effects recognized by the American Academy of Pediatrics guidelines on mold exposure. 9
The Institute of Medicine review found insufficient evidence to link mold exposure to any neuropsychiatric condition, including seizures. 9
Mycotoxin ingestion (e.g., through contaminated food in agricultural settings) can affect the central nervous system, but this route of exposure differs fundamentally from inhalation of indoor mold and therefore does not support a seizure‑causing relationship. 9

When patients present with neurological symptoms in a mold‑contaminated environment, clinicians should first evaluate for the established respiratory conditions (allergic rhinitis, asthma, sinusitis) using history, physical examination, and allergy testing (skin prick or specific IgE). 9
Alternative etiologies for neurological symptoms, including seizures, must be investigated before attributing them to mold exposure. 9
Mycotoxin testing in blood or urine is not recommended because standardized, validated assays for clinical use do not exist. 9